United States Peripheral Vascular Clot Management Interventions Market 2025 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth

Global Peripheral Vascular Clot Management Interventions Market is expected to reach at a high CAGR during the forecast period 2023-2030.

Key Development & Recent Mergers and Acquisitions:

United States: Recent Industry Developments

✅ In October 2025, Inquis Medical's AVENTUS Thrombectomy System received expanded clearance from the U.S. Food & Drug Administration (FDA) for treatment of pulmonary embolism after earlier clearance for the peripheral vasculature. The platform features integrated tissue‐sensing technology to guide precise clot removal with autologous blood reinfusion capability, addressing large clot burdens. This milestone underscores growing innovation in mechanical thrombectomy for peripheral and venous thromboembolic disease.

✅ In August 2025, Becton, Dickinson and Company (BD) launched the "XTRACT" real‐world data registry for its RotarexTM Atherectomy System to assess outcomes in U.S. patients with peripheral artery disease (PAD), including thrombus and plaque removal. The initiative will enroll up to 600 patients across ~100 sites and aims to provide comprehensive outcome evidence for this dual‐indication device (atherectomy + thrombectomy).

✅ In June 2025, Surmodics, Inc. secured FDA 510(k) clearance for its PounceTM XL Thrombectomy System, extending its platform to peripheral arteries up to 10 mm in diameter (from previous 2-6 mm range). This expands the clinical addressable market to larger iliac and femoral vessels and underscores the trend toward "grab‐and‐go" mechanical thrombectomy solutions without the need for thrombolytics.

✅ In January 2025, Stryker Corporation completed the acquisition of Inari Medical, Inc. for approximately USD 4.9 billion in cash, integrating Inari's venous‐thrombectomy and clot‐removal platforms into Stryker's peripheral vascular and endovascular device portfolio. This move strengthens Stryker's position in venous clot management and expands its device offerings for peripheral interventions.

Japan: Recent Industry Developments

✅ In July 2025, a leading Japanese medical‐technology firm acquired a domestic startup specialising in micro‐catheter and guidewire systems for endovascular thrombectomy. The acquisition enhances in‐country production and innovation capabilities for peripheral vascular clot‐removal devices in Japan, supporting faster device development and deployment.

✅ In February 2025, Terumo Corporation entered into a joint‐development and technology‐transfer agreement with a U.S.-based thrombectomy-device company to co-develop next‐generation aspiration systems optimised for Asian anatomical characteristics. While not a full acquisition, this strategic partnership strengthens Japan's capabilities in advanced clot‐management interventions.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/peripheral-vascular-clot-management-interventions-market?sb

Key Players:

=> Abbott Laboratories., Edward Lifesciences Corporation., Medtronic Inc., Teleflex Medical, Boston Scientific Corporation., Biotronik, Merit, B. Braun SE, Terumo Corporation, Penumbra Inc and among others.

Growth Forecast Projected:

The Global Peripheral Vascular Clot Management Interventions Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Peripheral Vascular Clot Management Interventions Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=peripheral-vascular-clot-management-interventions-market

Key Segments:

➥ By Device Type: Catheters, Endovascular Aneurysm Repair Stent Grafts, Inferior Vena Cava Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Other Peripheral Vascular Devices
➥ By Indication: Deep Vein Thrombosis (DVT), Pulmonary Artery Embolism
➥ By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics

Regional Analysis for Peripheral Vascular Clot Management Interventions Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Peripheral Vascular Clot Management Interventions producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Peripheral Vascular Clot Management Interventions revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/peripheral-vascular-clot-management-interventions-market?sb

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.